A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we present protocols for detecting nitric oxide and its biologically relevant derivatives using chemiluminescence-based assays with high sensitivity.

Abstract

Nitric oxide (NO) activity in vivo is the combined results of its direct effects, the action of its derivatives generated from NO autoxidation, and the effects of nitrosated compounds. Measuring NO metabolites is essential to studying NO activity both at vascular levels and in other tissues, especially in the experimental settings where exogenous NO is administered. Ozone-based chemiluminescence assays allow precise measurements of NO and NO metabolites in both fluids (including plasma, tissue homogenates, cell cultures) and gas mixtures (e.g., exhaled breath). NO reacts with ozone to generate nitrogen dioxide in an excited state. The consequent light emission allows photodetection and the generation of an electric signal reflecting the NO content of the sample. Aliquots from the same sample can be used to measure specific NO metabolites, such as nitrate, nitrite, S-nitrosothiols, and iron-nitrosyl complexes. In addition, NO consumed by cell-free hemoglobin is also quantified with chemiluminescence analysis. An illustration of all these techniques is provided.

Introduction

Since Salvador Moncada and Nobel laureates Robert Furchgott, Louis Ignarro, and Ferid Murad identified nitric oxide (NO) as the previously known endothelial-derived relaxation factor (EDRF), the central role of NO has been established in several key mechanisms spanning throughout vascular biology, neurosciences, metabolism, and host response1,2,3,4,5,6,7. Exogenous administration of NO gas has become an established treatment for respirato....

Protocol

The procedures indicated in this protocol are in accordance with the review board of Massachusetts General Hospital. The blood samples that were used had been collected during a previous study and were de-identified for the current purpose18.

NOTE: See manufacturer's instructions for specific guidance regarding optimal connections between tubing and glassware constituting the purge vessel, washing, and general maintenance. Connections need to be firm and carefully made not to damage the glassware. Identify the components of the glass purge vessel: gas inlet line, purge vessel with heating jacket and condenser, so....

Results

The NO-consumption by cell-free Hb assay was used in samples containing known concentrations of cell-free oxyHb (Figure 4). As one heme of oxyHb stoichiometrically releases one NO molecule in the assay, purified cell-free oxyHb is used to build the calibration curve for the assay (Supplemental Figure 3).

The dose-response relationship between cell-free Hb (measured with a colorimetric assay) and NO consumption in patients coming off cardiopulmonar.......

Discussion

Due to the high sensitivity, chemiluminescence-based assays for the determination of NO and related compounds have a high risk of NO2- contamination. Each reagent (especially the NO2- blocking solution) and dilutant (including ddH2O) used in the experiment should be tested for its NO2- content to correct for background signal. Nitrite is extremely reactive with a half-life in whole blood around 10 min and rapidly generates NO3-

Disclosures

L.B. receives salary support from K23 HL128882/NHLBI NIH as principal investigator for his work on hemolysis and nitric oxide. LB receives grants from "Fast Grants for COVID-19 research" at Mercatus Center of George Mason University and from iNO Therapeutics LLC. B.Y. is supported by grants from an NHLBI/#R21HL130956 and DOD/The Geneva Foundation (W81XWH-19-S-CCC1, Log DM190244). B.Y. received patents at MGH on the electric generation of nitric oxide.

L.B. and B.Y. have filed patent application for NO delivery in COVID-19 disease PCT application number: PCT/US2021/036269 filed on June 7, 2021. RWC receives salary support from Unitaid as the principal investigator for technology development aimed at decentralized diagnosis of tuberculosis in children located in low-resource settings.

Acknowledgements

The protocols reported in this manuscript were made possible by the accumulated contributions of previous fellows of Dr. Warren Zapol's laboratory of Anesthesia Research in Critical Care, Department of Anesthesia at Massachusetts General Hospital. We acknowledge the contribution of Drs. Akito Nakagawa, Francesco Zadek, Emanuele Vassena, Chong Lei, Yasuko Nagasaka, Ester Spagnolli and Emanuele Rezoagli.

....

Materials

NameCompanyCatalog NumberComments
Acetic AcidSigma45754500 mL - liquid
Antifoam B EmulsionSigmaA5757250 mL - liquid
DETA NONOateCayman8212010 mg
Gibco DPBS (1x) no calcium, no magnesiumThermoFisher14190144500 mL
Hydroochloric Acid 37% (1 M)Sigma258148500 mL - liquid
IodineSAFC207772100 g - solid
KimwipesKimtech34155
Mercury (II) Chloride ACS reagent> 99.5%Sigma215465100 g - solid (dissolve in water)
Mili-Q Water Purification SystemMillipore
Model 705 RN 50 μL syringeHamilton80530Microliter syringe
Model 802 N 25 μL SyringeHamilton84854Microliter syringe
N-ethylmaleimideSigma426025 g - crystalline
Nitric Oxide Analyzer + Bundle Software - Purge VesselZysenseNOA 280iChemiluminescence Detector
Nonidet p-40  (NP-40)ThermoFisher8512510% - 500 mL
Potassium hexacyanoferrate (III) ACS reagent≥ 99%Sigma244023100 g - powder
Potassium Iodide ACS reagent> 99%Sigma221945100 g - solid
Potassium Nitrite cryst. For analysis EMSURE ACSSupelco105067250 g - crystalline
PowerGen 125Fisher Scientific14-359-251Mechanic Homogenizer
RV3 Two Stage Rotary Vane PumpEdwardsA65201906Vacuum Pump - Bundled with analyzer
Sodium Heparin - BD Hemogard CloBD BiosciencesBD36787175 USP Units
Sodium hydroxide anhydrous ACS reagent ≥ 97%Sigma7954291 kg - pelletts
Sodium Nitrate ACS reagent ≥ 99%Sigma221341500 g - powder
Sodium nitrite ≥ 99%SigmaS2252500 g - crystalline
Sulfanilamide ≥ 98%SigmaS9251100 g - solid
Vanadium (III) ChlorideSigma11239325 g - solid - Caution (exothermic)
Whatman 1 Filter PaperSigmaWHA10010155

References

  1. Palmer, R. M. J., Ferrige, A. G., Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327 (6122), 524-526 (1987).
  2. Furchgott, R. F.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

ChemiluminescenceNitric OxideDETA NONOateOxygenPurge VesselInert GasMetabolitesAssayDetectionTherapeutic GasAntimicrobialAirway Infectious DiseasesLiquid Phase Assays

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved